United States of America
Tuberculosis profile
Population  2012 318 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.44 (0.39–0.48) 0.14 (0.12–0.15)
Mortality (HIV+TB only) 0.13 (0.11–0.19) 0.04 (0.03–0.06)
Prevalence  (includes HIV+TB) 15 (6.5–27) 4.7 (2–8.4)
Incidence  (includes HIV+TB) 11 (10–13) 3.6 (3.2–4.1)
Incidence (HIV+TB only) 1.1 (0.96–1.2) 0.35 (0.3–0.39)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 3 563 (36) Relapse    
Smear-negative 3 415 (34) Treatment after failure    
Smear-unknown / not done 846 (9) Treatment after default    
Extrapulmonary 2 100 (21) Other    
Other 21 (<1)      
Total new 9 945   Total retreatment    
           
Other (history unknown)          
Total new and relapse 9 945   Total cases notified 9 945  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.0 1.5 1.0
Age < 15 24 353 107
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 78   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 85  
Retreatment    
TB/HIV 2012 Number (%)
TB patients with known HIV status 8 376 (84)
HIV-positive TB patients 625 (7)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1 (0.8–1.3) 2.9 (1.4–5.4)
MDR-TB cases among notified pulmonary
TB cases
81 (63–100)   (–)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 6 790 (103%) 339 7 189
Laboratory-confirmed MDR-TB cases 70 10 81
Patients started on MDR-TB treatment     80
Financing TB control 2013
National TB programme budget (US$ millions) 137
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-23 Data: www.who.int/tb/data